Geron | GERN - Loan Capital


Geron reported $119.26M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Amgen USD 50B 2.43B Dec/2025
Bio Techne USD 260M 40M Dec/2025
Cassava Sciences USD 0 0 Dec/2024
Cytokinetics USD 1.12B 957.23M Dec/2025
Esperion Therapeutics USD 262.48M 235.95M Jun/2024
Genmab DKK 126M 6M Sep/2025
Geron USD 119.26M 273K Sep/2025
Gilead Sciences USD 22.14B 5M Sep/2025
Incyte USD 30.2M 5.17M Dec/2025
MacroGenics USD 70.26M 4K Sep/2025
Novartis USD 24.24B 174M Sep/2025
Novavax USD 223.63M 187K Sep/2024